The ubiquitin ligase CHIP acts as an upstream regulator of oncogenic pathways

Masashi Kajiro, Ryuichi Hirota, Yuka Nakajima, Kaori Kawanowa, Kae So-Ma, Ichiaki Ito, Yuri Yamaguchi, Sho Hei Ohie, Yasuhito Kobayashi, Yuko Seino, Miwako Kawano, Yoh Ichi Kawabe, Hiroyuki Takei, Shin Ichi Hayashi, Masafumi Kurosumi, Akiko Murayama, Keiji Kimura, Junn Yanagisawa

Research output: Contribution to journalArticle

113 Citations (Scopus)

Abstract

CHIP is a U-box-type ubiquitin ligase that induces ubiquitylation and degradation of its substrates, which include several oncogenic proteins. The relationship between CHIP and tumour progression, however, has not been elucidated. Here, we show that CHIP suppresses tumour progression in human breast cancer by inhibiting oncogenic pathways. CHIP levels were negatively correlated with the malignancy of human breast tumour tissues. In a nude mouse xenograft model, tumour growth and metastasis were significantly inhibited by CHIP expression. In contrast, knockdown of CHIP (shCHIP) in breast cancer cells resulted in rapid tumour growth and metastastic phenotypes in mice. In cell-based experiments, anchorage-independent growth and invasiveness of shCHIP cells was significantly elevated due to increased expression of Bcl2, Akt1, Smad and Twist. Proteomic analysis identified the transcriptional co-activator SRC-3 (refs 13, 14, 15, 16, 17, 18, 19) as a direct target for ubiquitylation and degradation by CHIP. Knocking down SRC-3 in shCHIP cells reduced the expression of Smad and Twist, and suppressed tumour metastasis in vivo. Conversely, SRC-3 co-expression prevented CHIP-induced suppression of metastasis formation. These observations demonstrate that CHIP inhibits anchorage-independent cell growth and metastatic potential by degrading oncogenic proteins including SRC-3.

Original languageEnglish (US)
Pages (from-to)312-319
Number of pages8
JournalNature Cell Biology
Volume11
Issue number3
DOIs
StatePublished - Feb 9 2009
Externally publishedYes

Fingerprint

Ligases
Ubiquitin
Neoplasms
Ubiquitination
Breast Neoplasms
Growth
Neoplasm Metastasis
Heterografts
Nude Mice
Proteomics
Proteins
Phenotype

ASJC Scopus subject areas

  • Cell Biology

Cite this

Kajiro, M., Hirota, R., Nakajima, Y., Kawanowa, K., So-Ma, K., Ito, I., ... Yanagisawa, J. (2009). The ubiquitin ligase CHIP acts as an upstream regulator of oncogenic pathways. Nature Cell Biology, 11(3), 312-319. https://doi.org/10.1038/ncb1839

The ubiquitin ligase CHIP acts as an upstream regulator of oncogenic pathways. / Kajiro, Masashi; Hirota, Ryuichi; Nakajima, Yuka; Kawanowa, Kaori; So-Ma, Kae; Ito, Ichiaki; Yamaguchi, Yuri; Ohie, Sho Hei; Kobayashi, Yasuhito; Seino, Yuko; Kawano, Miwako; Kawabe, Yoh Ichi; Takei, Hiroyuki; Hayashi, Shin Ichi; Kurosumi, Masafumi; Murayama, Akiko; Kimura, Keiji; Yanagisawa, Junn.

In: Nature Cell Biology, Vol. 11, No. 3, 09.02.2009, p. 312-319.

Research output: Contribution to journalArticle

Kajiro, M, Hirota, R, Nakajima, Y, Kawanowa, K, So-Ma, K, Ito, I, Yamaguchi, Y, Ohie, SH, Kobayashi, Y, Seino, Y, Kawano, M, Kawabe, YI, Takei, H, Hayashi, SI, Kurosumi, M, Murayama, A, Kimura, K & Yanagisawa, J 2009, 'The ubiquitin ligase CHIP acts as an upstream regulator of oncogenic pathways', Nature Cell Biology, vol. 11, no. 3, pp. 312-319. https://doi.org/10.1038/ncb1839
Kajiro, Masashi ; Hirota, Ryuichi ; Nakajima, Yuka ; Kawanowa, Kaori ; So-Ma, Kae ; Ito, Ichiaki ; Yamaguchi, Yuri ; Ohie, Sho Hei ; Kobayashi, Yasuhito ; Seino, Yuko ; Kawano, Miwako ; Kawabe, Yoh Ichi ; Takei, Hiroyuki ; Hayashi, Shin Ichi ; Kurosumi, Masafumi ; Murayama, Akiko ; Kimura, Keiji ; Yanagisawa, Junn. / The ubiquitin ligase CHIP acts as an upstream regulator of oncogenic pathways. In: Nature Cell Biology. 2009 ; Vol. 11, No. 3. pp. 312-319.
@article{5828c14fa0a249dfb54d4ac7fb12cbe4,
title = "The ubiquitin ligase CHIP acts as an upstream regulator of oncogenic pathways",
abstract = "CHIP is a U-box-type ubiquitin ligase that induces ubiquitylation and degradation of its substrates, which include several oncogenic proteins. The relationship between CHIP and tumour progression, however, has not been elucidated. Here, we show that CHIP suppresses tumour progression in human breast cancer by inhibiting oncogenic pathways. CHIP levels were negatively correlated with the malignancy of human breast tumour tissues. In a nude mouse xenograft model, tumour growth and metastasis were significantly inhibited by CHIP expression. In contrast, knockdown of CHIP (shCHIP) in breast cancer cells resulted in rapid tumour growth and metastastic phenotypes in mice. In cell-based experiments, anchorage-independent growth and invasiveness of shCHIP cells was significantly elevated due to increased expression of Bcl2, Akt1, Smad and Twist. Proteomic analysis identified the transcriptional co-activator SRC-3 (refs 13, 14, 15, 16, 17, 18, 19) as a direct target for ubiquitylation and degradation by CHIP. Knocking down SRC-3 in shCHIP cells reduced the expression of Smad and Twist, and suppressed tumour metastasis in vivo. Conversely, SRC-3 co-expression prevented CHIP-induced suppression of metastasis formation. These observations demonstrate that CHIP inhibits anchorage-independent cell growth and metastatic potential by degrading oncogenic proteins including SRC-3.",
author = "Masashi Kajiro and Ryuichi Hirota and Yuka Nakajima and Kaori Kawanowa and Kae So-Ma and Ichiaki Ito and Yuri Yamaguchi and Ohie, {Sho Hei} and Yasuhito Kobayashi and Yuko Seino and Miwako Kawano and Kawabe, {Yoh Ichi} and Hiroyuki Takei and Hayashi, {Shin Ichi} and Masafumi Kurosumi and Akiko Murayama and Keiji Kimura and Junn Yanagisawa",
year = "2009",
month = "2",
day = "9",
doi = "10.1038/ncb1839",
language = "English (US)",
volume = "11",
pages = "312--319",
journal = "Nature Cell Biology",
issn = "1465-7392",
publisher = "Nature Publishing Group",
number = "3",

}

TY - JOUR

T1 - The ubiquitin ligase CHIP acts as an upstream regulator of oncogenic pathways

AU - Kajiro, Masashi

AU - Hirota, Ryuichi

AU - Nakajima, Yuka

AU - Kawanowa, Kaori

AU - So-Ma, Kae

AU - Ito, Ichiaki

AU - Yamaguchi, Yuri

AU - Ohie, Sho Hei

AU - Kobayashi, Yasuhito

AU - Seino, Yuko

AU - Kawano, Miwako

AU - Kawabe, Yoh Ichi

AU - Takei, Hiroyuki

AU - Hayashi, Shin Ichi

AU - Kurosumi, Masafumi

AU - Murayama, Akiko

AU - Kimura, Keiji

AU - Yanagisawa, Junn

PY - 2009/2/9

Y1 - 2009/2/9

N2 - CHIP is a U-box-type ubiquitin ligase that induces ubiquitylation and degradation of its substrates, which include several oncogenic proteins. The relationship between CHIP and tumour progression, however, has not been elucidated. Here, we show that CHIP suppresses tumour progression in human breast cancer by inhibiting oncogenic pathways. CHIP levels were negatively correlated with the malignancy of human breast tumour tissues. In a nude mouse xenograft model, tumour growth and metastasis were significantly inhibited by CHIP expression. In contrast, knockdown of CHIP (shCHIP) in breast cancer cells resulted in rapid tumour growth and metastastic phenotypes in mice. In cell-based experiments, anchorage-independent growth and invasiveness of shCHIP cells was significantly elevated due to increased expression of Bcl2, Akt1, Smad and Twist. Proteomic analysis identified the transcriptional co-activator SRC-3 (refs 13, 14, 15, 16, 17, 18, 19) as a direct target for ubiquitylation and degradation by CHIP. Knocking down SRC-3 in shCHIP cells reduced the expression of Smad and Twist, and suppressed tumour metastasis in vivo. Conversely, SRC-3 co-expression prevented CHIP-induced suppression of metastasis formation. These observations demonstrate that CHIP inhibits anchorage-independent cell growth and metastatic potential by degrading oncogenic proteins including SRC-3.

AB - CHIP is a U-box-type ubiquitin ligase that induces ubiquitylation and degradation of its substrates, which include several oncogenic proteins. The relationship between CHIP and tumour progression, however, has not been elucidated. Here, we show that CHIP suppresses tumour progression in human breast cancer by inhibiting oncogenic pathways. CHIP levels were negatively correlated with the malignancy of human breast tumour tissues. In a nude mouse xenograft model, tumour growth and metastasis were significantly inhibited by CHIP expression. In contrast, knockdown of CHIP (shCHIP) in breast cancer cells resulted in rapid tumour growth and metastastic phenotypes in mice. In cell-based experiments, anchorage-independent growth and invasiveness of shCHIP cells was significantly elevated due to increased expression of Bcl2, Akt1, Smad and Twist. Proteomic analysis identified the transcriptional co-activator SRC-3 (refs 13, 14, 15, 16, 17, 18, 19) as a direct target for ubiquitylation and degradation by CHIP. Knocking down SRC-3 in shCHIP cells reduced the expression of Smad and Twist, and suppressed tumour metastasis in vivo. Conversely, SRC-3 co-expression prevented CHIP-induced suppression of metastasis formation. These observations demonstrate that CHIP inhibits anchorage-independent cell growth and metastatic potential by degrading oncogenic proteins including SRC-3.

UR - http://www.scopus.com/inward/record.url?scp=61849088969&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=61849088969&partnerID=8YFLogxK

U2 - 10.1038/ncb1839

DO - 10.1038/ncb1839

M3 - Article

VL - 11

SP - 312

EP - 319

JO - Nature Cell Biology

JF - Nature Cell Biology

SN - 1465-7392

IS - 3

ER -